Search for: "FOREST LABORATORIES INC"
Results 21 - 40
of 160
Sorted by Relevance
|
Sort by Date
28 Aug 2008, 4:24 am
The class action In re Forest Laboratories, Inc. [read post]
29 Jul 2008, 3:01 pm
., 4:06-md-01736 (RWS), a Multidistrict Litigation with approximately 42 cases alleging suicidal injuries caused by either Celexa or Lexapro, the defendants, Forest Laboratories, Inc. and Forest Pharmaceuticals, Inc. moved to dismiss 22 of the cases on conflict preemption grounds. [read post]
27 Feb 2009, 9:03 pm
Nonpracticing New Jersey physician Joseph Piacentile "now makes a living suing drug companies," and the new action in which his name figures against Forest Laboratories follows earlier suits he's helped instigate against Medco Health Solutions, Bristol-Myers Squibb, and Cephalon Inc.... [read post]
4 Apr 2019, 6:15 am
(Alembic) and Breckenridge Pharmaceuticals, Inc. [read post]
3 Mar 2009, 12:06 pm
Forest Laboratories Inc. is charged with influencing doctors with cash payments disguised as grants. [read post]
23 Mar 2008, 7:52 pm
Forest Laboratories, Inc. et al. v. [read post]
4 Dec 2012, 6:30 am
On November 28, 2012, Forest Laboratories, Inc. [read post]
30 Dec 2012, 3:30 am
Patent Business: Deals, Licenses, Settlements – Dec. 4, 2012On November 28, 2012, Forest Laboratories, Inc. [read post]
16 Sep 2010, 12:00 pm
The Department of Justice also announced that Forest Pharmaceuticals, Inc. and its parent company, Forest Laboratories, Inc., have agreed to pay $149 million and to enter into a Corporate Integrity Agreement with the Office of Inspector General of the U.S. [read post]
17 Oct 2003, 8:13 am
Manufactured by Forest Laboratories, Inc., the drug is the first on the US market to treat moderate to advanced Alzheimer's. [read post]
21 Jun 2012, 4:41 pm
Plaintiff Forest Laboratories, Inc. [read post]
5 Sep 2007, 11:40 am
Case: Forest Laboratories, Inc. v. [read post]
5 Sep 2007, 11:40 am
Case: Forest Laboratories, Inc. v. [read post]
21 Oct 2009, 9:54 pm
District Court for the Southern District of New York has awarded Infosint $15 million as a reasonable royalty in Infosint's patent dispute with Lundbeck A/S and Forest Laboratories, Inc. over the patent covering Lexapro ®. [read post]
18 Apr 2011, 6:05 pm
"Forest Laboratories, Inc. [read post]
28 Aug 2014, 5:09 pm
Jon LaPook presented the story, which suggested that the motivation was the continued patent coverage on Namenda XR.Forest had made an announcement on February 14, 2014: Forest Laboratories, Inc. [read post]
6 Sep 2007, 12:33 pm
See Forest Laboratories v. [read post]
22 Apr 2016, 2:54 pm
’s and co-defendant Forest Laboratories, Inc. [read post]
4 Apr 2019, 6:15 am
(Alembic) and Breckenridge Pharmaceuticals, Inc. [read post]
13 Jul 2016, 7:05 am
" Forest Laboratories Inc. et al v. [read post]
